108 related articles for article (PubMed ID: 849997)
1. Bioavailability of a sustained-release dyphylline formulation.
Simons KJ; Simons FE; Bierman CW
J Clin Pharmacol; 1977 Apr; 17(4):237-41. PubMed ID: 849997
[TBL] [Abstract][Full Text] [Related]
2. Comparative bioavailability of sustained-release and conventional tablets of hydroxyethyltheophylline in man.
Sharma PL; Sharma RM
Int J Clin Pharmacol Biopharm; 1979 Sep; 17(9):394-6. PubMed ID: 583044
[TBL] [Abstract][Full Text] [Related]
3. Bioavailability of dyphylline and dyphylline-guaifenesin tablets in humans.
Straughn AB; Wood GC; Raghow G; Meyer MC
J Pharm Sci; 1985 Mar; 74(3):335-7. PubMed ID: 4009445
[TBL] [Abstract][Full Text] [Related]
4. Urinary excretion of dyphylline in humans.
Simons KJ; Simons FE
J Pharm Sci; 1979 Oct; 68(10):1327-9. PubMed ID: 512873
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and bioavailability of three dyphylline preparations.
Stablein JJ; Samaan SS; Bukantz SC; Lockey RF
Eur J Clin Pharmacol; 1983; 25(2):281-3. PubMed ID: 6628514
[TBL] [Abstract][Full Text] [Related]
6. [Prolongation of theophylline derivative release with cellulose acetate based tablets].
Guyonnet T; Brossard C; Lefort des Ylouses D
J Pharm Belg; 1990; 45(2):111-9. PubMed ID: 2355304
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a new sustained-release theophylline tablet for children.
Selvig K; Alme A; Rugstad HE; Aas K; Bjerve KS
Acta Paediatr Scand; 1981 Nov; 70(6):929-33. PubMed ID: 7324949
[TBL] [Abstract][Full Text] [Related]
8. Effect of food on the bioavailability and pattern of release of a sustained-release theophylline tablet.
Leeds NH; Gal P; Purohit AA; Walter JB
J Clin Pharmacol; 1982 Apr; 22(4):196-200. PubMed ID: 7096605
[TBL] [Abstract][Full Text] [Related]
9. Dissolution studies of some regular and sustained-release dyphylline dosage forms.
Simons KJ; Plett KD; Simons FE
Pharm Acta Helv; 1984; 59(5-6):145-8. PubMed ID: 6739505
[No Abstract] [Full Text] [Related]
10. Pharmacokinetics of sustained release and conventional tablets of theophylline plus hydroxyethyltheophylline and its comparison with tablet aminophylline.
Gupta S; Raina RK; Samotra K; Gupta KL
Indian J Chest Dis Allied Sci; 1991; 33(1):1-8. PubMed ID: 1791015
[TBL] [Abstract][Full Text] [Related]
11. Absorption of theophylline from conventional and sustained-release tablets.
Mellstrand T; Svedmyr N; Fagerström PO
Eur J Respir Dis Suppl; 1980; 109():54-60. PubMed ID: 6934088
[TBL] [Abstract][Full Text] [Related]
12. A multiple-dose study of sustained-release theophylline and aminophylline.
Meyer MC; Straughn AB; Lieberman P
Chest; 1980 Aug; 78(2):300-3. PubMed ID: 7398417
[TBL] [Abstract][Full Text] [Related]
13. Serum profile and bioavailability of a controlled-release theophylline formulation for once-daily use: comparison with a 12-hr preparation.
Cohen BM
J Asthma; 1984; 21(5):305-9. PubMed ID: 6389484
[TBL] [Abstract][Full Text] [Related]
14. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
Schuppan D; Molz KH; Staib AH; Rietbrock N
Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
[TBL] [Abstract][Full Text] [Related]
15. Dissolution and bioavailability studies of whole and halved sustained-release theophylline tablets.
Simons KJ; Frith EM; Simons FE
J Pharm Sci; 1982 May; 71(5):505-11. PubMed ID: 7097493
[TBL] [Abstract][Full Text] [Related]
16. A comparison of steady state plasma theophylline concentrations with conventional and sustained release formulations.
Mellstrand T; Svedmyr K; Svedmyr N
Eur J Respir Dis; 1982 Jan; 63(1):31-4. PubMed ID: 7040098
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of a sustained-release theophylline formulation.
Trembath PW; Boobois SW
Br J Clin Pharmacol; 1980 Apr; 9(4):365-9. PubMed ID: 7378252
[TBL] [Abstract][Full Text] [Related]
18. An in vivo single- and multiple-dose study of several marketed brands of conventional and controlled-release theophylline.
Kotzan JA; Vallner JV; Stewart JT; Honigberg IL; Brown WJ
Drug Intell Clin Pharm; 1984 Feb; 18(2):147-53. PubMed ID: 6697877
[TBL] [Abstract][Full Text] [Related]
19. The relation of product formulation to absorption of oral theophylline.
Weinberger M; Hendeles L; Bighley L
N Engl J Med; 1978 Oct; 299(16):852-7. PubMed ID: 692577
[TBL] [Abstract][Full Text] [Related]
20. Absorption of theophylline from conventional and sustained-release tablets.
Fagerström PO; Mellstrand T; Svedmyr N
Int J Clin Pharmacol Ther Toxicol; 1981 Mar; 19(3):131-8. PubMed ID: 7228455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
